Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Sat, 09/2/17 - 11:11 am
Tags:
Parkinson's Disease, Novartis, Teva Pharmaceutial, UCB Pharma, MEDI1341, AstraZeneca, Takeda, PRX002, Prothena, Roche, Acorda, Inbrija, Adamas Pharmaceuticals, Gocovri
Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Endpoints
Thu, 08/31/17 - 09:28 am
Tags:
AstraZeneca, Daiichi Sankyo, M&A
AstraZeneca auctions off rights to another pipeline drug as Takeda grabs $400M Parkinson’s deal
Endpoints
Tue, 08/29/17 - 10:54 am
Tags:
AstraZeneca, Takeda, MEDI1341, Parkinson's Disease
AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting
Yahoo/Zacks.com
Mon, 08/28/17 - 09:35 am
Tags:
AstraZeneca, Faslodex, FDA, advanced breast cancer
With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC
Fierce Pharma
Thu, 08/24/17 - 11:25 am
Tags:
AstraZeneca, Brilinta, blood thinners
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Yahoo/Zacks.com
Wed, 08/23/17 - 11:14 am
Tags:
Pfizer, Ibrance, breast cancer, Faslodex, AstraZeneca
Struggling AstraZeneca ups the ante on mRNA pipeline work
Endpoints
Mon, 08/21/17 - 09:42 am
Tags:
AstraZeneca, MRNA, R&D, Ethris, respiratory health
Ovarian Cancer Market Still Up For Grabs
Barron's
Sat, 08/19/17 - 10:48 am
Tags:
ovarian cancer, Lynparza, Tesaro, AstraZeneca, Clovis Oncology
Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza
Endpoints
Thu, 08/17/17 - 11:54 pm
Tags:
Tesaro, AstraZeneca, Merck, FDA, Lynparza, Zejula
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
Tags:
patents, AbbVie, Humira, Pfizer, Lipitor, Norvasc, GSK, Advair, Sanofi, Lantus, JNJ, Remicade, AstraZeneca, Crestor, Nexium, Amgen, Neulasta, Novartis, Diovan
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
Tags:
pharma stocks, Merck, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, GSK, Roche, Sanofi, Bayer, Novo Nordisk, Celgene, Biogen, AstraZeneca
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Fri, 08/4/17 - 11:41 am
Tags:
Pfizer, AstraZeneca, Big Pharma, biotech
Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib
Endpoints
Wed, 08/2/17 - 09:50 am
Tags:
AstraZeneca, FDA, acalabrutinib, Btk inhibitors
Expecting Big Pharma buyers to come running after weakened AstraZeneca? Not so fast
Fierce Pharma
Tue, 08/1/17 - 11:12 pm
Tags:
AstraZeneca, M&A, Pfizer
GlaxoSmithKline GLP-1 Tanzeum meets its end, and it doesn't bode well for Sanofi, AstraZeneca: analyst
Fierce Pharma
Tue, 08/1/17 - 10:48 pm
Tags:
GSK, GLP-1 agonist, Tanzeum, Sanofi, AstraZeneca
AstraZeneca fights back in cancer with new hires, fast drug status
Yahoo/Reuters
Mon, 07/31/17 - 09:56 am
Tags:
AstraZeneca, Imfinzi, immuno-oncology
Prescribed Reading: Pharma marked by restructuring and failures
BioPharma Dive
Fri, 07/28/17 - 10:40 pm
Tags:
restructuring, M&A, AstraZeneca, Mystic
Bristol shrugs off comparisons to MYSTIC
BioPharma Dive
Fri, 07/28/17 - 11:38 am
Tags:
AstraZeneca, Bristol-Myers Squibb, Mystic, immuno-oncology, Opdivo
AstraZeneca, Merck team up on Lynparza combos in collaboration worth up to $8.5B
Fierce Pharma
Fri, 07/28/17 - 11:31 am
Tags:
AstraZeneca, Merck, Lynparza, Imfinzi
A humbling setback for an immune-revving cancer therapy underscores the many questions facing the field
Stat
Thu, 07/27/17 - 07:44 pm
Tags:
AstraZeneca, Mystic, immuno-oncology

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.